T50.995S
T50.995S: Adverse effect of other drugs, medicaments and biological substances, sequela
Billable / specific codeICD-10-CMPOA exempt
T50.995S is a billable, specific ICD-10-CM code for adverse effect of other drugs, medicaments and biological substances, sequela. It is valid for submission on a claim.
Check T50.995S with the rest of the claim: free scrubber7th character "S": sequela
The appropriate 7th character is to be added to each code from category T50
- A
- initial encounter
- D
- subsequent encounter
- S
- sequela
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Medicare coverage
T50.995S is named in 27 Medicare coverage policies: 27 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A52399Billing and Coding: Denosumab (Prolia®, Xgeva®, Jubbonti®) and biosimilars
- A52421Billing and Coding: Ibandronate Sodium
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A56531Billing and Coding: Octreotide Acetate for Injectable Suspension (Sandostatin® LAR Depot)
Code history
Unchanged in every release from FY2024 to FY2027.